![]() | |
![]() | |
Clinical data | |
---|---|
Trade names | Alimta, Pemfexy, Ciambra, others |
AHFS/Drugs.com | Monograph |
License data |
|
Pregnancy category |
|
Routes of administration | Intravenous |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | NA |
Protein binding | 81% |
Metabolism | Negligible |
Elimination half-life | 3.5 hours |
Excretion | Kidney |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.205.735 |
Chemical and physical data | |
Formula | C20H21N5O6 |
Molar mass | 427.417 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Pemetrexed, sold under the brand name Alimta among others, is a chemotherapy medication for the treatment of pleural mesothelioma and non-small cell lung cancer (NSCLC).[2]
It is available as a generic medication.[6][7]
Alimta FDA label
was invoked but never defined (see the help page).© MMXXIII Rich X Search. We shall prevail. All rights reserved. Rich X Search